NCT03680716View on ClinicalTrials.gov

Combined Saphenous Nerve and IPACK Blocks Versus Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
Postoperative PainAnterior Cruciate Ligament InjuryAnterior Cruciate Ligament Rupture
Interventions
DRUG

Ropivacaine injection

Saphenous nerve block with 20ml of ropivacaine 0.5% and IPACK block with 30ml of ropivacaine 0.2% (total dose of 160 mg).

DRUG

Ropivacaine injection

Periarticular infiltration of 80 ml ropivacaine 0.2% (total dose of 160mg).

Trial Locations (1)

1011

Department of Anesthesia, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT03680716 - Combined Saphenous Nerve and IPACK Blocks Versus Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction | Biotech Hunter | Biotech Hunter